Comparative studies would provide valuable insights into the differential impacts of individual SGLT-2 inhibitors on heart failure outcomes. By acknowledging and discussing these limitations, the review fosters a more critical appraisal of the findings and identifies areas where further research is necessary. The gene discussed is SLC5A2; the disease is heart failure.